| ACHN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ACHN shares outstanding history going back to 3/9/2010:
Also see: ACHN Market Cap History ACHN YTD Return |
ACHN Shares Outstanding History — Achillion Pharmaceuticals Share Count Over Time
As of 11/1/2019 Achillion Pharmaceuticals has 140.05 million ACHN shares outstanding. Investors often track the ACHN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ACHN share count trends over time, with 39 historical shares outstanding datapoints presented, dating back to 3/9/2010.
| ACHN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACHN Historical Shares Outstanding: +14.31% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ACHN Stock Price Chart |
| About Achillion Pharmaceuticals Inc |
| Achillion Pharmaceuticals is a biopharmaceutical company. Co. is engaged in the discovery and development of small molecule drug therapies for immune system disorders. Co. is advancing orally administered small molecules from its platform that target complement factor D, an essential protein of the alternative pathway. The alternative pathway plays a role in a number of disease conditions, including therapeutic areas of nephrology, hematology, ophthalmology and neurology. Initially Co. is targeting C3 glomerulopathy, and immune complex membranoproliferative glomerulonephritis, two related rare diseases affecting the kidney, and paroxysmal nocturnal hemoglobinuria, a blood disorder. We show 39 historical shares outstanding datapoints in our coverage of ACHN's shares outstanding history. Understanding the changing numbers of ACHN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ACHN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ACHN by allowing them to research ACHN shares outstanding history as well as any other stock in our coverage universe. |
| ACHN Current Stock Quote |
Quotes delayed 20 minutes  Free ACHN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ACHN Share Performance |
| Shares Outstanding Peers |
| Achillion Pharmaceuticals (ACHN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ACHV Shares Outstanding History ACLX Shares Outstanding History ACON Shares Outstanding History ACOR Shares Outstanding History ACRS Shares Outstanding History ACRV Shares Outstanding History ACRX Shares Outstanding History ACST Shares Outstanding History ACTU Shares Outstanding History ACXP Shares Outstanding History More Healthcare companies » |
ACHN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
